Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/EBIT

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/EBIT(x) 10.875.359.7111.3063.75

What is the latest EV/EBIT ratio of NATCO PHARMA ?

The latest EV/EBIT ratio of NATCO PHARMA is 10.87 based on Mar2026 Consolidated results.
Year EV/EBIT
Mar202610.87
Mar20255.35
Mar20249.71
Mar202311.30
Mar202263.75

How is EV/EBIT of NATCO PHARMA Trending?

Years EV/EBIT % Change
Mar2026 10.87
103.18
Mar2025 5.35
-44.90
Mar2024 9.71
-14.07
Mar2023 11.3
-82.27
Mar2022 63.75 -

Other Financial Ratios of NATCO PHARMA


Compare EV/EBIT ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,018.4 Cr -1.3% -8.6% -4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,826.0 Cr -1.6% -2.5% 21.4% Stock Analytics
DIVIS LABORATORIES ₹247,019.0 Cr 1.5% 12.8% 48.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,875.0 Cr -0.9% -0.8% 35.3% Stock Analytics
CIPLA ₹112,773.0 Cr -1.6% -5.2% -11.7% Stock Analytics
DR REDDYS LABORATORIES ₹95,570.9 Cr -2.2% -2.3% -8.2% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.3%

-8.6%

-4.2%

SENSEX

-1.1%

-3.6%

-5.3%


You may also like the below Video Courses